Projecting 25.2% year-over-year sales growth, Globus Medical projects Q4 2025 revenue of $823.2 million. Analysts, on the ...

Globus Medical (GMED) is back in focus after its preliminary fourth quarter 2025 revenue of about US$823.2 million topped ...

Medical sector leader Globus Medical is in a buy zone from a cup-with-handle base that has a buy point of 92.48.

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales ...

Across the recent three months, 8 analysts have shared their insights on Globus Medical (NYSE:GMED), expressing a variety of opinions spanning from bullish to bearish. The table below provides a ...

Globus Medical recently reported preliminary fourth-quarter 2025 revenue of about US$823.2 million and full-year 2025 sales ...

What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Kline, Senior Vice President at Globus Medical, a company in the Health Care sector, just ...

Across the recent three months, 11 analysts have shared their insights on Globus Medical (NYSE:GMED), expressing a variety of opinions spanning from bullish to bearish. Summarizing their recent ...

So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, ...

Globus Medical’s full-year revenue for 2025 is projected to reach nearly $3 billion, according to preliminary financial results. Full-year revenue in 2025 is expected to increase 25.2% year over year ...

Globus Medical reports quarterly earnings of 72 cents per share which beat the analyst consensus estimate of 57 cents by 26.32%. Quarterly sales come in at $606.67 million which beat the analyst ...

Globus Medical’s second quarter sales for 2025 reached $745.3 million, a year-over-year increase of 18.4%, led largely by its U.S. spine business. The company, which is a top player in the ...